Investigating how specific proteins affect RNA processing and degradation
The Roles of Rnt1 and Putative Endoribonucleases in mRNA Processing and Degradation
['FUNDING_FELLOWSHIP'] · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · NIH-11003665
This study is looking at how specific proteins help control the way our genes work by managing messenger RNA, which could lead to better understanding and treatments for patients with conditions like cancer and rare inherited diseases.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-11003665 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding how certain proteins regulate gene expression by processing and degrading messenger RNA (mRNA). By identifying the targets and cleavage sites of these proteins, the study aims to uncover the mechanisms that maintain cellular health and prevent diseases like cancer and neurodegenerative disorders. Patients may benefit from insights gained into the genetic causes of their conditions, particularly those with rare inherited diseases linked to RNA regulation. The research employs advanced bioinformatics techniques to analyze the roles of these proteins in cellular processes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with rare inherited diseases, cancers, or neurodegenerative disorders related to RNA processing and degradation.
Not a fit: Patients with conditions unrelated to RNA regulation or those not affected by genetic dysregulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into the genetic causes of diseases and potential therapeutic targets for treatment.
How similar studies have performed: Previous research has shown success in understanding RNA regulation and its implications for various diseases, indicating that this approach is promising.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NOTICE, LEE-ANN SHARI — UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
- Study coordinator: NOTICE, LEE-ANN SHARI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers